Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine

Drug Office - Pharmaceutical Trade Homepage

Drug Office - Pharmaceutical Trade Homepage

藥物辦公室– 藥劑業界主頁

PDF) Pseudoephedrine—Benefits and Risks

Frontiers Posterior Reversible Encephalopathy Syndrome After Self-Medication With an Oral Decongestant: A Case Report

SciELO - Brasil - Acute hepatic porphyrias for the neurologist: current concepts and perspectives Acute hepatic porphyrias for the neurologist: current concepts and perspectives

药物办公室– 药剂业界主页

药物办公室- 消费者主页

Posterior Reversible Encephalopathy Syndrome and brain haemorrhage as COVID-19 complication: a review of the available literature

其他安全警示- 2024-03-18 (1)

Cerebrovascular Dysregulation: Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome.

Cerebrovascular Dysregulation: Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome.

藥物辦公室– 藥劑業界主頁